Literature DB >> 34953074

Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk.

Danielle E Whittier1, Elizabeth J Samelson2,3, Marian T Hannan2,3, Lauren A Burt1, David A Hanley1, Emmanuel Biver4, Pawel Szulc5, Elisabeth Sornay-Rendu5, Blandine Merle5, Roland Chapurlat5, Eric Lespessailles6,7, Andy Kin On Wong8,9, David Goltzman10, Sundeep Khosla11, Serge Ferrari4, Mary L Bouxsein12,13,14, Douglas P Kiel2,3, Steven K Boyd1.   

Abstract

Prevalence of osteoporosis is more than 50% in older adults, yet current clinical methods for diagnosis that rely on areal bone mineral density (aBMD) fail to detect most individuals who have a fragility fracture. Bone fragility can manifest in different forms, and a "one-size-fits-all" approach to diagnosis and management of osteoporosis may not be suitable. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides additive information by capturing information about volumetric density and microarchitecture, but interpretation is challenging because of the complex interactions between the numerous properties measured. In this study, we propose that there are common combinations of bone properties, referred to as phenotypes, that are predisposed to different levels of fracture risk. Using HR-pQCT data from a multinational cohort (n = 5873, 71% female) between 40 and 96 years of age, we employed fuzzy c-means clustering, an unsupervised machine-learning method, to identify phenotypes of bone microarchitecture. Three clusters were identified, and using partial correlation analysis of HR-pQCT parameters, we characterized the clusters as low density, low volume, and healthy bone phenotypes. Most males were associated with the healthy bone phenotype, whereas females were more often associated with the low volume or low density bone phenotypes. Each phenotype had a significantly different cumulative hazard of major osteoporotic fracture (MOF) and of any incident osteoporotic fracture (p < 0.05). After adjustment for covariates (cohort, sex, and age), the low density followed by the low volume phenotype had the highest association with MOF (hazard ratio = 2.96 and 2.35, respectively), and significant associations were maintained when additionally adjusted for femoral neck aBMD (hazard ratio = 1.69 and 1.90, respectively). Further, within each phenotype, different imaging biomarkers of fracture were identified. These findings suggest that osteoporotic fracture risk is associated with bone phenotypes that capture key features of bone deterioration that are not distinguishable by aBMD.
© 2021 American Society for Bone and Mineral Research (ASBMR). © 2021 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  BONE; FRACTURE RISK; HIGH-RESOLUTION PERIPHERAL COMPUTED TOMOGRAPHY; MACHINE LEARNING; OSTEOPOROSIS; PHENOTYPE

Mesh:

Year:  2022        PMID: 34953074      PMCID: PMC9249128          DOI: 10.1002/jbmr.4494

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.390


  45 in total

1.  Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images.

Authors:  W Pistoia; B van Rietbergen; E-M Lochmüller; C A Lill; F Eckstein; P Rüegsegger
Journal:  Bone       Date:  2002-06       Impact factor: 4.398

2.  Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: a population-based HR-pQCT study.

Authors:  Heather M Macdonald; Kyle K Nishiyama; Jian Kang; David A Hanley; Steven K Boyd
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

3.  In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.

Authors:  Stephanie Boutroy; Mary L Bouxsein; Francoise Munoz; Pierre D Delmas
Journal:  J Clin Endocrinol Metab       Date:  2005-09-27       Impact factor: 5.958

4.  A Crisis in the Treatment of Osteoporosis.

Authors:  Sundeep Khosla; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2016-06-28       Impact factor: 6.741

5.  Evidence for two distinct syndromes of involutional osteoporosis.

Authors:  B L Riggs; L J Melton
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

6.  Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR-pQCT Study.

Authors:  Elizabeth J Samelson; Serkalem Demissie; L Adrienne Cupples; Xiaochun Zhang; Hanfei Xu; Ching-Ti Liu; Steven K Boyd; Robert R McLean; Kerry E Broe; Douglas P Kiel; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2017-09-20       Impact factor: 6.741

7.  Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.

Authors:  Dan Mellström; Olof Johnell; Osten Ljunggren; Anna-Lena Eriksson; Mattias Lorentzon; Hans Mallmin; Anna Holmberg; Inga Redlund-Johnell; Eric Orwoll; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

Review 8.  Osteoporosis prevention, diagnosis, and therapy.

Authors: 
Journal:  JAMA       Date:  2001-02-14       Impact factor: 56.272

Review 9.  Epidemiology of osteoporotic fractures.

Authors:  Olof Johnell; John Kanis
Journal:  Osteoporos Int       Date:  2004-09-08       Impact factor: 4.507

10.  Bone Phenotype Assessed by HRpQCT and Associations with Fracture Risk in the GLOW Study.

Authors:  A E Litwic; L D Westbury; D E Robinson; K A Ward; C Cooper; E M Dennison
Journal:  Calcif Tissue Int       Date:  2017-09-14       Impact factor: 4.333

View more
  2 in total

1.  Genetic Deletion of Menin in Mouse Mesenchymal Stem Cells: An Experimental and Computational Analysis.

Authors:  Jad Abi-Rafeh; Meisam Asgari; Ildi Troka; Lucie Canaff; Ahmed Moussa; Damiano Pasini; David Goltzman
Journal:  JBMR Plus       Date:  2022-04-07

Review 2.  Proton Pump Inhibitors and Bone Health: An Update Narrative Review.

Authors:  Eric Lespessailles; Hechmi Toumi
Journal:  Int J Mol Sci       Date:  2022-09-14       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.